The global isoflavones market is set to witness growth at a CAGR of 5.5% and top a valuation of US$ 2.3 Bn by 2032. Isoflavones can exhibit better anti-inflammatory activities through increased anti-oxidative properties, for which there are several medical conditions which can be improved with the usage of isoflavones. For instance, consumers who eat a high isoflavones-based soy diet in their adolescent years can possess a little risk of breast cancer later.
Also, isoflavones from fermented soy or soy protein can effectively reduce blood sugar, thus inhibiting type 2 diabetes in humans. Even the isoflavones-based soy formula supplementation can remove the diarrhea conditions in infants when compared to cow milk drinking formula. According to research, isoflavones from soy can strongly reduce the bad cholesterol known as LDL, thus inhibiting the high cholesterol level of blood.
Furthermore, the isoflavones sources which are protein-based food, such as tempeh, tofu, and other related products contains very lower amount of cholesterol, and isoflavones supplements made from such sources are proven well effective in managing blood cholesterol levels in human body. Along with that, soy-based isoflavones may also lower the blood pressure when taken in certain conditions.
Consumers with the symptoms of IBS (irritable bowel syndrome) can take up isoflavones-based diet effectively in their food chart to improve the symptoms conditions and to lower the abdominal pain. Menopausal symptoms, such as depression, irritability, and hot flashes can also be reduced with isoflavones-based diet. Even soy-based isoflavones supplements can increase bone density, thus reducing the risk of osteoporosis.
All of the aforementioned factors are enhancing the demand for isoflavones increasing among consumers with each passing day and manufacturers are being motivated to come up with new range of products with different forms and applications to meet up the demand well.
Key Takeaways from Market Study
The isoflavones market is worth of US$ 1.4 Bn sales in 2022.
The isoflavones market is expected to expand at CAGRs of 5.5% through 2032.
Global isoflavones demand is projected to grow year-on-year (Y-o-Y) growth of 5.2% in 2022.
The isoflavones market is growing with a notable boost towards the production to reach USD 2.3 Bn by 2032.
Healthy raw materials, packaging, and improved cleaner label products to be the influencing factors among consumers, which is driving sales of isoflavones across global markets.
Demand for isoflavones grew at 4.6% CAGR between 2017 and 2021.
Cargill, Inc., Archer Daniels Midland Company, BASF SE, International Flavors and Fragrances, and NutraScience Labs are expected to be the top players in the industry.
Organic natured, liquid form segment and soy-based isoflavones are in heavy demand from dietary and pharmaceuticals industry carrying a notable market share.
“The emerging isoflavones-based diet for its nutritional profile and ability to create healthy dietary supplements and nutraceuticals based on specific applications related to several health conditions starting from menopausal syndromes to treatment for heart disease and osteoporosis have created huge demand for the product among consumers over the time period,” says a Future Market Insights analyst.
Competitive Landscape
Key brands associated with isoflavones are focusing on sustainable product developments, while also extending the product lines with several modifications and extensive research procedures to boost the industry growth and to capture more market share in global arena.
Ø The Japanese company Otsuka Pharmaceutical Co., Ltd, has created soy isoflavones named as EQUELLE, which is focused on equol, a component produced when the specific ingredient of soy isoflavones, daidzein is metabolized by the intestinal bacteria to generate a more powerful result than any crude soy isoflavones.
Ø Archer Daniels Midland Company is offering its soy isoflavones under the name NovaSoy®, which is a plant-based product and can be found on almost as large as 125 supplement brands all over the world.
Explore More Valuable Insights
Future Market Insights, in its new report, offers an impartial analysis of the global isoflavones market, presenting historical data (2017-2021) and estimation statistics for the forecast period of 2022-2032.
The study offers compelling insights based on nature (organic and conventional), form (powder, liquid, and wax), source (soybean, peanut, chickpea, clover, and others), and application (food & beverages, nutraceuticals & dietary supplements, pharmaceuticals, cosmetics & personal care, and others), across seven major regions of the world.
Information Source: https://www.futuremarketinsights.com/reports/isoflavones-market
Latest Research Report on “Sports Medicine Products Market” Added by Analytical Research Cognizance which covers Market Overview, Future Economic Impact, Competition by Manufacturers, Supply (Production), & Consumption Analysis
This report studies the global market size of Sports Medicine Products Market in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sports Medicine Products in these regions.
This report also studies the global Sports Medicine Products market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Get Sample for Sports Medicine Products Market Report @ http://www.arcognizance.com/enquiry-sample/131077
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Market size by End User
With the advent of technological innovations and advancements, the ERP software market is expanding its dimensions all across the globe.
The market size of ERP in North America is worth more than $10 billion Read more....
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.
These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.
Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.
Recently published a report entitled Food Grade Isoflavones Market projected till 2026, added by Value Market Research, covers key players along with their market share and strategic development adopted by them.
Further, the report provides market size, share, trends, outlook and forecast based on historical data coupled with drivers, restraints, and opportunities.The study offers a decisive view of the global food grade isoflavones market by segmenting it in terms of type and application.
The report analyzes these subsets with respect to the regional segmentation.
This research study will prepare marketers for the evolving needs of their customers.Request a FREE Sample Copy of Food Grade Isoflavones Market Report with Full TOC At: https://www.valuemarketresearch.com/contact/food-grade-isoflavones-market/download-sampleBy TypePurity 40%Purity 60%Purity≥80%By ApplicationFood IndustryDietary SupplementsOthersThis research report also includes profiles of major companies operating in the global market.
Some of the prominent players operating in the global food grade isoflavones market are Archer Daniels Midland, Bio-Gen Extracts, Frutarom Health, Fujicco, Future Ceuticals, Herbo Nutra, and Solbar Industries.
This section cover profiling of major players in terms of important aspects such as company overview, financial overview, business strategy, and recent developments undertaken during the forecast horizon.This section covers food grade isoflavones market for the regions North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
This report studies the global market size of Robotic Surgery Systems in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Robotic Surgery Systems in these regions.
This report also studies the global Robotic Surgery Systems market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Market size by End User
Rest of Central & South America
The study objectives of this report are:
To study and analyze the global Robotic Surgery Systems market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
